Terms: = Uterine cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Diagnosis
119 results:
1. MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome.
Helderman NC; Andini KD; van Leerdam ME; van Hest LP; Hoekman DR; Ahadova A; Bajwa-Ten Broeke SW; Bosse T; van der Logt EMJ; Imhann F; Kloor M; Langers AMJ; Smit VTHBM; Terlouw D; van Wezel T; Morreau H; Nielsen M
J Mol Diagn; 2024 Feb; 26(2):106-114. PubMed ID: 38061582
[TBL] [Abstract] [Full Text] [Related]
2. Metastasis of endometrial adenocarcinoma masquerading as a primary rectal cancer: A rare case report with literature review.
Li M; Zheng W
Medicine (Baltimore); 2023 Nov; 102(46):e36170. PubMed ID: 37986305
[TBL] [Abstract] [Full Text] [Related]
3. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
[No Abstract] [Full Text] [Related]
4. Comparison of Methods for Testing Mismatch Repair Status in Endometrial cancer.
Mendiola M; Heredia-Soto V; Ruz-Caracuel I; Baillo A; Ramon-Patino JL; Escudero FJ; Miguel M; Pelaez-Garcia A; Hernandez A; Feliu J; Hardisson D; Redondo A
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833916
[TBL] [Abstract] [Full Text] [Related]
5. A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer.
Wang C; Kuang W; Zeng J; Ren Y; Liu Q; Sun H; Feng M; Liang D
PeerJ; 2023; 11():e15920. PubMed ID: 37663290
[TBL] [Abstract] [Full Text] [Related]
6. Clear cell endometrial carcinoma with high microsatellite instability in a complicated pregnancy: a case report.
Weiss F; Kaltofen T; Kanitz V; Schröder L; Kost B; König A; Delius M; Mahner S; Alba Alejandre I
J Med Case Rep; 2023 Jul; 17(1):286. PubMed ID: 37422672
[TBL] [Abstract] [Full Text] [Related]
7. [Clinicopathological and gene mutation characteristics of uterine carcinosarcoma].
Tu J; Xu JZ; Zhang YS; Deng LF
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(24):1864-1867. PubMed ID: 37357193
[TBL] [Abstract] [Full Text] [Related]
8. Incidence and prevalence of advanced colorectal neoplasia in Lynch syndrome.
Sleiman J; Farha N; Beard J; Bena J; Morrison S; Milicia S; Heald B; Kalady MF; Church J; Liska D; Mankaney G; Burke CA
Gastrointest Endosc; 2023 Sep; 98(3):412-419.e8. PubMed ID: 37031913
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
Yang Z; Yang X; Liu X; Ma K; Meng YT; Yin HF; Wen J; Yang JH; Zhen Z; Feng ZH; Liao QP
BMC Cancer; 2023 Mar; 23(1):243. PubMed ID: 36918828
[TBL] [Abstract] [Full Text] [Related]
10. The statuses of HER2 expression and mismatch repair in endometrial clear cell carcinoma.
Bayramoglu Z; Erozbek SY; Ozdemir IA; Ulker V; Muezzinoglu B
Pathol Res Pract; 2023 Jan; 241():154258. PubMed ID: 36516643
[TBL] [Abstract] [Full Text] [Related]
11. High MutS homolog 2 expression predicts poor prognosis and is related to immune infiltration in endometrial carcinoma.
Lu X; Ying Y; Zhang W; Li R; Zhang J
Cell Biol Int; 2023 Jan; 47(1):201-215. PubMed ID: 36208091
[TBL] [Abstract] [Full Text] [Related]
12. [A family with clustered Lynch syndrome: a case report].
Zhu X; Cai L; Xiao J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1263-1266. PubMed ID: 36073228
[TBL] [Abstract] [Full Text] [Related]
13. Impact of the new molecular classification of endometrial cancer: A French cohort study.
Benichou J; Schwall C; Sastre-Garau X; Méreaux J; Miailhe G; Bendifallah S; Haddad B; Touboul C; Mitri-Frangieh R; Dabi Y
Gynecol Oncol; 2022 Sep; 166(3):515-521. PubMed ID: 35843738
[TBL] [Abstract] [Full Text] [Related]
14. The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma.
Ye S; Zhou S; Zhong S; Shan B; Jiang W; Yang W; Cai X; Yang H
BMC Cancer; 2022 Apr; 22(1):449. PubMed ID: 35461222
[TBL] [Abstract] [Full Text] [Related]
15. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract] [Full Text] [Related]
16. Endometrial cancer in Lynch syndrome.
Zhao S; Chen L; Zang Y; Liu W; Liu S; Teng F; Xue F; Wang Y
Int J Cancer; 2022 Jan; 150(1):7-17. PubMed ID: 34398969
[TBL] [Abstract] [Full Text] [Related]
17. Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and PALB2 in endometrial cancer.
Johnatty SE; Pesaran T; Dolinsky J; Yussuf A; LaDuca H; James PA; O'Mara TA; Spurdle AB
Hum Mutat; 2021 Oct; 42(10):1265-1278. PubMed ID: 34245638
[TBL] [Abstract] [Full Text] [Related]
18. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
Wen YL; Yan SM; Wei W; Yang X; Zhang SW; Yun JP; Liu LL; Luo RZ
Mol Med; 2021 Jun; 27(1):60. PubMed ID: 34134633
[TBL] [Abstract] [Full Text] [Related]
19. Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers.
Evans DG; Lalloo F; Ryan NA; Bowers N; Green K; Woodward ER; Clancy T; Bolton J; McVey RJ; Wallace AJ; Newton K; Hill J; McMahon R; Crosbie EJ
J Med Genet; 2022 Apr; 59(4):328-334. PubMed ID: 33452216
[TBL] [Abstract] [Full Text] [Related]
20. [Nice-Saint-Paul de Vence 2020 recommendations for clinical practice: Management of metastatic and/or relapsing endometrial cancer].
Alexandre J; Le Frere-Belda MA; Prulhiere K; Treilleux I; Leary A; Pomel C; Chargari C; Ducassou A; Joly F;
Bull Cancer; 2020 Oct; 107(10):1006-1018. PubMed ID: 32958220
[TBL] [Abstract] [Full Text] [Related]
[Next]